Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Telstar Promotes Latest Generation of Freeze Dryers in Dubai

By LabMedica International staff writers
Posted on 31 Jan 2019
Telstar (Shanghai, China) displayed the latest generation of compact laboratory freeze dryers at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. More...
The event saw more than 19,610 unique visitors and 678+ exhibitors sharing the most recent technology available in the IVD, and medical laboratory market.

Among its products exhibited at MedLab Middle East 2019 was the Telstar LyoQuest, a bench-top laboratory freeze dryer that combines this breadth of functionality into a single unit so that users can perform complete cycles on a range of sample containers (vials, trays, ampoules, and flasks) using the same piece of equipment. LyoQuest also enables users to create recipes comprising time, temperature and vacuum control via its integrated PLC control system. Its innovative design results in an extremely compact unit with large condensation capacity up to eight liters and enables many product formats to be pre-frozen by the device, without the need for an additional freezer. The LyoQuest’s ice condenser includes an automatic defrosting function for quick and easy de-icing.

The company also promoted the Telstar Bio II Advance Plus compact range of microbiological safety cabinets (MSC) that are intended for the laminar flow manipulation of microorganisms with biological risk levels 2 and 3. Their innovative cabinet design offers smaller body than the market average while maintaining standard workspace. With dimensions of 759 mm in width and 1260 mm in height, the Bio II Advance Plus provides a working volume of 340 dm3. Equipped to achieve maximum efficiency, this new range of MSC integrates energy saving EC fans and LED illumination that ensures optimum protection levels as well as low energy consumption. Bio II Advance Plus is designed in compliance with the European standards EN 12469 and certified by TÜV-Nord.

Telstar also displayed Boreas, a new -86º ultra-low-temperature freezer designed to increase average performance by 20% and featuring an innovative mechanical design that enhances robustness, efficiency and ergonomics as well as ensures the integrity of the cold preservation process. Equipped with vacuum panels VIP, the freezer guarantees the highest level of thermal insulation and a temperature of -80ºC under an ambient up to +28ºC. Unlike standard freezers designed with panels based on polyurethane foam, a thinner inner insulation provides Boreas with an enlarged storage capacity of up to 30%. Boreas uses high purity natural refrigerant gases to contribute to environment preservation and does not damage the ozone layer. The ecological ultra-low-freezers line has been developed using Telstar’s in-house cold storage technology.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Portable Electronic Pipette
Mini 96
New
Automatic Hematology Analyzer
DH-800 Series
New
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dormant tumor cells evade imaging tests and may later reactivate to spread metastatic breast cancer (Photo courtesy of David A. Litman/Shutterstock)

MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence

Breast cancer survival rates continue to improve, but recurrence remains incurable and affects around 30% of patients. Some subtypes, like triple negative and HER2+, relapse within years, while ER+ cancers... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.